ES445151A1 - Un metodo de recuperar productos quimicos valiosos de la le-jia de desecho residual en un procedimiento de formacion de pasta de madera. - Google Patents

Un metodo de recuperar productos quimicos valiosos de la le-jia de desecho residual en un procedimiento de formacion de pasta de madera.

Info

Publication number
ES445151A1
ES445151A1 ES445151A ES445151A ES445151A1 ES 445151 A1 ES445151 A1 ES 445151A1 ES 445151 A ES445151 A ES 445151A ES 445151 A ES445151 A ES 445151A ES 445151 A1 ES445151 A1 ES 445151A1
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
compositions
solvent
formulation
steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES445151A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Babcock and Wilcox Co
Original Assignee
Babcock and Wilcox Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Babcock and Wilcox Co filed Critical Babcock and Wilcox Co
Publication of ES445151A1 publication Critical patent/ES445151A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
ES445151A 1975-02-21 1976-02-13 Un metodo de recuperar productos quimicos valiosos de la le-jia de desecho residual en un procedimiento de formacion de pasta de madera. Expired ES445151A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/551,811 US3934013A (en) 1975-02-21 1975-02-21 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ES445151A1 true ES445151A1 (es) 1977-05-16

Family

ID=24202770

Family Applications (1)

Application Number Title Priority Date Filing Date
ES445151A Expired ES445151A1 (es) 1975-02-21 1976-02-13 Un metodo de recuperar productos quimicos valiosos de la le-jia de desecho residual en un procedimiento de formacion de pasta de madera.

Country Status (18)

Country Link
US (1) US3934013A (es)
JP (1) JPS6135166B2 (es)
AU (1) AU504748B2 (es)
BE (1) BE838711A (es)
BR (1) BR7600834A (es)
CA (1) CA1067409A (es)
DE (1) DE2605242A1 (es)
DK (1) DK68876A (es)
ES (1) ES445151A1 (es)
FI (1) FI67415C (es)
FR (1) FR2301262A1 (es)
GB (1) GB1502544A (es)
IE (1) IE43655B1 (es)
IL (1) IL48797A (es)
IT (1) IT1066085B (es)
NL (1) NL7601667A (es)
NZ (1) NZ180042A (es)
ZA (1) ZA7671B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
BE861876A (fr) * 1976-12-17 1978-06-15 Scherico Ltd Nouvelles formulations d'antibiotiques beta-lactame leur procede de preparation, melange antibiotique injectable ainsi que son procede de preparation
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
US4482539A (en) * 1983-05-13 1984-11-13 Schering Corporation Betamethasone dipropionate cream
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
EP0196121A1 (en) * 1985-02-22 1986-10-01 Pera Dr. Visnjic Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
US5002936A (en) * 1985-04-12 1991-03-26 Seymour Lieberman Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds
US4780455A (en) * 1985-04-12 1988-10-25 The Trustees Of Columbia University In The City Of New York Lipophilic complexes of pharmacologically active organic compounds
US4792556A (en) 1985-09-09 1988-12-20 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
DE3534743A1 (de) * 1985-09-28 1987-04-02 Beiersdorf Ag Hydrocortisondiester enthaltende o/w-creme
US4740372A (en) * 1986-09-17 1988-04-26 Ljubomir Boncic Composition for treating psoriasis vulgaris and a method for its preparation
US5171737A (en) * 1989-03-03 1992-12-15 The Liposome Company, Inc. Emulsions
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
DE4234225A1 (de) * 1992-10-10 1994-04-14 Roehm Pharma Gmbh Stabile topische Formulierungen mit gutem Wirkstoff-Freisetzungsvermögen enthaltend mindestens ein lipophilisiertes Makrolidantibiotikum
DE69427589T2 (de) * 1993-10-22 2002-04-25 Smithkline Beecham Corp Neue zusammensetzung
WO1996002254A1 (en) * 1994-07-15 1996-02-01 Michel Cohen SYNERGISTIC PHARMACEUTICAL COMPOSITONS CONTAINING 16'alpha',17'alpha'-ISOPROPYLIDENEDIOXY SUBSTITUTED PREGNANES
US5707981A (en) * 1994-07-28 1998-01-13 Psorial, L.L.C. Synergistic pharmaceutical compositions
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
ES2232434T3 (es) 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
EP2309858A4 (en) 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
EP2473161B1 (en) 2009-08-31 2017-05-17 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
PL2366408T3 (pl) 2010-03-01 2013-01-31 Salvat Lab Sa Klarowne roztwory wodne acetonidu fluocinolonu do leczenia zapalenia uszu
ES2857602T3 (es) 2014-03-11 2021-09-29 Promius Pharma Llc Composiciones tópicas de corticosteroides
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
PL409156A1 (pl) 2014-08-11 2016-02-15 Matonis Grzegorz Kompozycja kosmetyczna i/lub farmaceutyczna łagodząca objawy łuszczycy
EP3651753A4 (en) * 2017-07-11 2021-05-05 University Of Miami TOPICAL ACETAMINOPHEN FORMULATIONS FOR ITCH RELIEF
AU2021318201A1 (en) 2020-07-28 2023-02-02 Arcutis Biotherapeutics, Inc. Topical formulation containing jak inhibitor and laureth-4

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073743A (en) * 1959-07-30 1963-01-15 Upjohn Co Antiinflammatory steroid acetonide compositions and therapy
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides

Also Published As

Publication number Publication date
JPS51110043A (es) 1976-09-29
AU1085876A (en) 1977-03-17
NZ180042A (en) 1978-07-28
AU504748B2 (en) 1979-10-25
IL48797A0 (en) 1976-03-31
FI760344A (es) 1976-08-22
ZA7671B (en) 1977-08-31
BE838711A (fr) 1976-08-19
AU1068276A (en) 1977-08-04
IE43655L (en) 1976-08-21
IL48797A (en) 1979-01-31
IT1066085B (it) 1985-03-04
FI67415B (fi) 1984-11-30
JPS6135166B2 (es) 1986-08-12
BR7600834A (pt) 1976-09-14
FR2301262A1 (fr) 1976-09-17
DK68876A (da) 1976-08-22
CA1067409A (en) 1979-12-04
DE2605242A1 (de) 1976-09-02
FI67415C (fi) 1985-03-11
IE43655B1 (en) 1981-04-22
GB1502544A (en) 1978-03-01
FR2301262B1 (es) 1979-04-06
NL7601667A (nl) 1976-08-24
US3934013A (en) 1976-01-20

Similar Documents

Publication Publication Date Title
ES445151A1 (es) Un metodo de recuperar productos quimicos valiosos de la le-jia de desecho residual en un procedimiento de formacion de pasta de madera.
EP0292893B2 (en) Steroid lotion
JO1250B1 (en) New pharmaceutical preparations
IE39936L (en) Pharmaceutical and/or cosmetic preparations
US4101652A (en) Pharmaceutically active complexes and pharmaceutical compositions containing eascin and sterols
IE43693L (en) Androstane derivatives
ES445488A1 (es) Un procedimiento para la preparacion de un 16alfa-retinoato,un 17alfa-retinoato yno un 21-retinoato de un esteroide.
HU173950B (hu) Sposob poluchenija al'fa-al'fa-dvoezamehhennykh proizvodnykh uksusnojj kisloty i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
GB1467947A (en) Steroid compositions and processes for their preparation
DE2709078C2 (de) Neue Halogen-Derivate der Reihe des 16α-Methylpregnans, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
HU198841B (en) Process for producing composition suitable for treating psoriasis
AR241488A1 (es) Procedimiento para preparar nuevas 17 beta-n,n-dietilcarbamoil-4-metil-4-aza-5alfa-androstan-3-onas utiles como inhibidores de 5alfa-reductasa.
SE7614304L (sv) Nya karboxylsyraderivat och sett for deras framstellning
US3342676A (en) Dermatological composition containing 21-desoxy-9-alpha-fluoro-6-methyl prednisolone
IT1049449B (it) Derivati dell acido acetico aventi attivita farmacologica e composizioni che li contengono
US3320127A (en) 21-desoxy-9-alpha-fluoro-6-methylprednisolone dermatological compositions
US3200038A (en) Topical anti-rheumatic compositions comprising tetrahydrofurfuryl 3-pyridylacetate
FR2598M (fr) Nouveaux dérivés de l'acide anthrauilique, utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
WO1993017687A1 (en) Topical compositions containing steroids
DE1919811C3 (de) 21 (Poly-beta-äthoxy-äthyl)-Kohlensäureester von 3,20-Dioxo-9 alpha-fluor-11 beta,21-dihydroxy-16 alpha-methyl-17 alpha-R-1,4-pregnadienen, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE1793526C3 (de) 4,9,11-Trien-Steroid
GB1013180A (en) Steroid compositions
KR20040034795A (ko) 스테로이드 제제 및 태반 추출물을 함유한 염증성 피부병치료용 경피제
Aramoto et al. A case of contact dermatitis due to methylprednisolone
GB347126A (en) Remedial preparations for application to the hair and scalp